Skip to content
10-Q

Quarterly Report

INNOVATION PHARMACEUTICALS INC.

0001477932-21-003093

← back to feed
Filed
May 13, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · May 10, 2021 418.16M sh
Current Liabilities Q3 2021 · Mar 31, 2021 $6.42M
Current Liabilities Q3 2021 · Jun 30, 2020 $7.37M
Total Liabilities Q3 2021 · Mar 31, 2021 $6.72M
Total Liabilities Q3 2021 · Jun 30, 2020 $7.79M
Current Assets Q3 2021 · Mar 31, 2021 $13.06M
Current Assets Q3 2021 · Jun 30, 2020 $6.11M
Total Assets Q3 2021 · Mar 31, 2021 $16.92M
Total Assets Q3 2021 · Jun 30, 2020 $9.25M
Sga Expense Q3 2021 · Mar 31, 2021 $740K
Sga Expense Q3 2021 · Mar 31, 2020 $461K
Sga Expense Q3 2021 · Mar 31, 2020 $1.08M
Rd Expense Q3 2021 · Mar 31, 2021 $4.92M
Rd Expense Q3 2021 · Mar 31, 2020 $276K
Rd Expense Q3 2021 · Mar 31, 2020 $1.89M
Operating Income Q3 2021 · Mar 31, 2021 −$6.49M
Operating Income Q3 2021 · Mar 31, 2020 −$925K
Operating Income Q3 2021 · Mar 31, 2020 −$3.21M
Revenue Q3 2021 · Mar 31, 2021 $0
Revenue Q3 2021 · Mar 31, 2020 $0
Revenue Q3 2021 · Mar 31, 2020 $400K
Operating Cash Flow Q3 2021 · Mar 31, 2020 −$2.33M
Cash And Equivalents Q3 2021 · Mar 31, 2020 $775K
Cash And Equivalents Q3 2021 · Jun 30, 2019 $579K
Stockholders Equity Q3 2021 · Mar 31, 2020 −$4.47M
Stockholders Equity Q3 2021 · Dec 31, 2019 −$5.62M
Stockholders Equity Q3 2021 · Sep 30, 2019 −$4.54M
Stockholders Equity Q3 2021 · Jun 30, 2019 −$4.13M
Net Income Q3 2021 · Mar 31, 2020 −$995K
Net Income Q3 2021 · Mar 31, 2020 −$5.17M